The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Biogen Idec to Present at the DB Access BioFEST Conference

Monday, November 26, 2012

Biogen Idec to Present at the DB Access BioFEST Conference16:01 EST Monday, November 26, 2012 WESTON, Mass. (Business Wire) -- Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the DB Access BioFEST Conference will be webcast live on Monday, December 3, 2012 at 8:25 a.m. ET. To access the live webcast, please visit Biogen Idec's Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation. About Biogen Idec Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com. Biogen IdecKaren Jewell, 781-464-2442Investor Relations